Literature DB >> 6180183

Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen.

T C Spelsberg, T B Sculley, G M Pikler, J A Gilbert, G R Pearson.   

Abstract

A new class of Epstein-Barr virus nuclear antigen (EBNA) was identified by the complement fixation assay. This new species of EBNA is more tightly bound to chromatin and was termed class II EBNA, as opposed to the more weakly associated species, class I EBNA. Preparations of this new antigen(s) specifically reduced absorption with the titer of anti-EBNA antibodies as determined by the anticomplement immunofluorescence assay. Therefore, the complement fixation antigens (class II EBNA) appear to be related to the classical EBNA (class I EBNA). The class I EBNA was found to focus at the same pH (4.6) as the soluble antigen found in the cytosol. The class II EBNA differed from the class I EBNA with regard to its overall charge, molecular size, antigenicity, and affinity for chromatin. The class II EBNA appeared to be a basic protein, based on its apparent pI of 9.2 and its binding to cation-exchange resins. It differed from histones with regard to its molecular size (molecular weight between 60,000 and 70,000) and its elution from hydroxylapatite chromatography. Steps were taken to prevent proteolysis and artifacts in the immunological assays and in the overall charge estimation of the new antigen by nonspecific basic histone protein-acidic protein interactions. Both class I and class II EBNA were identified by radioimmunoelectrophoresis on two-dimensional polyacrylamide gels with pI values of 5.0 and 8.5, respectively, and a molecular weight range of 60,000 to 70,000 for both. A lower-molecular-weight antigen identified by molecular sieve chromatography appeared to be due to interference by histones in the immunoassays since it was not observed by the two-dimensional gel electrophoresis. Further characterization of this class II EBNA is in progress.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180183      PMCID: PMC256159     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Studies on the infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cells.

Authors:  F E Durr; J H Monroe; R Schmitter; K A Traul; Y Hirshaut
Journal:  Int J Cancer       Date:  1970-11-15       Impact factor: 7.396

2.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

3.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors:  M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  A simple colorimetric method for determination of protein.

Authors:  S Bramhall; N Noack; M Wu; J R Loewenberg
Journal:  Anal Biochem       Date:  1969-10-01       Impact factor: 3.365

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Proteins of chromatin in template restriction. II. Specificity of RNA synthesis.

Authors:  T C Spelsberg; L S Hnilica
Journal:  Biochim Biophys Acta       Date:  1971-01-01

8.  Proteins of chromatin in template restriction. 3. The macromolecules in specific restriction of the chromatin DNA.

Authors:  T C Spelsberg; L S Hnilica; A T Ansevin
Journal:  Biochim Biophys Acta       Date:  1971-01-28

9.  Progesterone-binding components of chick oviduct. 3. Chromatin acceptor sites.

Authors:  T C Spelsberg; A W Steggles; B W O'Malley
Journal:  J Biol Chem       Date:  1971-07-10       Impact factor: 5.157

10.  Structure studies on chromatin and nucleohistones. Thermal denaturation profiles recorded in the presence of urea.

Authors:  A T Ansevin; L S Hnilica; T C Spelsberg; S L Kehm
Journal:  Biochemistry       Date:  1971-12-07       Impact factor: 3.162

View more
  8 in total

1.  Induction of Epstein-Barr virus nuclear antigens.

Authors:  D J Moss; T B Sculley; J H Pope
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

2.  Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis.

Authors:  T B Sculley; P J Walker; D J Moss; J H Pope
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

3.  Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen.

Authors:  J Luka; T Kreofsky; G R Pearson; K Hennessy; E Kieff
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

4.  Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.

Authors:  E A Grogan; W P Summers; S Dowling; D Shedd; L Gradoville; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.

Authors:  D K Fischer; M F Robert; D Shedd; W P Summers; J E Robinson; J Wolak; J E Stefano; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.

Authors:  K Hennessy; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide.

Authors:  P B Billings; S O Hoch; P J White; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.

Authors:  J Dillner; B Kallin; G Klein; H Jörnvall; H Alexander; R Lerner
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.